Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
HK Stock MarketDetailed Quotes
ELIFE HLDGS (00223)
- 0.128
- +0.002+1.59%
Trading May 6 13:28 CST
208.31MMarket Cap-9.14P/E (TTM)
0.137High0.126Low2.04MVolume0.127Open0.126Prev Close262.18KTurnover0.13%Turnover RatioLossP/E (Static)1.63BShares0.28552wk High3.66P/B208.31MFloat Cap0.11152wk Low--Dividend TTM1.63BShs Float23.157Historical High--Dividend LFY8.73%Range %0.070Historical Low0.129Avg Price20000Lot Size--Div Yield TTM--Div Yield LFY
ELIFE HLDGS (00223) Cash Flow
All
YOY
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -269.70%-95.07M | ---- | -2.03%-25.72M | ---- | 47.20%-25.2M | ---- | -64.98%-47.73M | ---- | 69.85%-28.93M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 65.87%-314K | ---- | 15.98%-920K | ---- | 14.52%-1.1M | ---- | 51.59%-1.28M | ---- | 26.25%-2.65M |
| Impairment and provisions: | ---- | 26.06%34.98M | ---- | 2,565.80%27.75M | ---- | -93.01%1.04M | ---- | 1,729.12%14.89M | ---- | -97.63%814K |
| -Impairment of property, plant and equipment (reversal) | ---- | 73,500.00%736K | ---- | -92.31%1K | ---- | --13K | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 17.86%32.5M | ---- | 6,139.37%27.58M | ---- | -97.03%442K | ---- | 1,729.12%14.89M | ---- | -90.80%814K |
| -Other impairments and provisions | ---- | 914.53%1.75M | ---- | -70.65%172K | ---- | --586K | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | ---- | --40.83M | ---- | ---- | ---- | 26.67%-44K | ---- | -105.28%-60K | ---- | -52.49%1.14M |
| -Loss (gain) from sale of subsidiary company | ---- | --40.66M | ---- | ---- | ---- | ---41K | ---- | ---- | ---- | ---336K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | --167K | ---- | ---- | ---- | 95.00%-3K | ---- | -3,100.00%-60K | ---- | -99.92%2K |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.47M |
| Depreciation and amortization: | ---- | -4.98%2.02M | ---- | -24.77%2.13M | ---- | -16.52%2.83M | ---- | -39.55%3.39M | ---- | -42.07%5.61M |
| Financial expense | ---- | -60.40%830K | ---- | -7.34%2.1M | ---- | -9.12%2.26M | ---- | 44.12%2.49M | ---- | 202.98%1.73M |
| Exchange Loss (gain) | ---- | 0.00%1K | ---- | -99.36%1K | ---- | 15,800.00%157K | ---- | -100.55%-1K | ---- | 369.23%183K |
| Special items | ---- | ---- | ---- | ---- | ---- | -100.18%-22K | ---- | 44.88%12.07M | ---- | 360.64%8.33M |
| Operating profit before the change of operating capital | ---- | -412.97%-16.72M | ---- | 126.61%5.34M | ---- | -23.68%-20.07M | ---- | -17.83%-16.23M | ---- | 72.86%-13.78M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -82.04%144K | ---- | 136.09%802K | ---- | -397.09%-2.22M | ---- | -698.21%-447K | ---- | -106.33%-56K |
| Accounts receivable (increase)decrease | ---- | 142.18%68.13M | ---- | -1,764.14%-161.51M | ---- | 146.79%9.71M | ---- | -268.84%-20.74M | ---- | -143.32%-5.62M |
| Accounts payable increase (decrease) | ---- | -161.10%-84.24M | ---- | 11,289.53%137.86M | ---- | -154.34%-1.23M | ---- | 146.03%2.27M | ---- | 49.91%-4.93M |
| prepayments (increase)decrease | ---- | 115.48%2.53M | ---- | -816.13%-16.35M | ---- | -108.28%-1.79M | ---- | 54.76%21.55M | ---- | -41.64%13.93M |
| Special items for working capital changes | ---- | -98.06%96K | ---- | 754.56%4.96M | ---- | -195.94%-757K | ---- | 626.00%789K | ---- | -70.45%-150K |
| Cash from business operations | ---- | -3.98%-30.05M | ---- | -76.62%-28.9M | ---- | -27.73%-16.37M | ---- | -20.82%-12.81M | ---- | 53.81%-10.6M |
| Other taxs | ---- | ---2.86M | ---- | ---- | ---- | 98.28%-33K | ---- | -644.57%-1.92M | ---- | -6,350.00%-258K |
| Special items of business | 24.56%-18.76M | ---- | -300.16%-24.87M | ---- | 19.15%-6.21M | ---- | 10.28%-7.69M | ---- | -64.94%-8.57M | ---- |
| Net cash from operations | 24.56%-18.76M | -13.88%-32.92M | -300.16%-24.87M | -76.27%-28.9M | 19.15%-6.21M | -11.30%-16.4M | 10.28%-7.69M | -35.64%-14.73M | -64.94%-8.57M | 52.70%-10.86M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 450.00%22K | ---- | 33.33%4K | ---- | -88.46%3K | ---- | -13.33%26K | ---- | 100.00%30K |
| Sale of fixed assets | ---- | --250K | ---- | ---- | ---- | -51.67%29K | ---- | 1,100.00%60K | ---- | -99.48%5K |
| Purchase of fixed assets | ---- | -10,900.00%-220K | ---- | 95.24%-2K | ---- | ---42K | ---- | ---- | ---- | -68.25%-106K |
| Sale of subsidiaries | ---- | --12K | ---- | ---- | ---- | ---31K | ---- | ---- | ---- | --336K |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4K | ---- | ---- |
| Other items in the investment business | -102.32%-6K | ---- | 26,000.00%259K | ---- | 92.86%-1K | ---- | -111.38%-14K | --5.77M | 547.37%123K | ---- |
| Net cash from investment operations | -102.32%-6K | 3,100.00%64K | 26,000.00%259K | 104.88%2K | 92.86%-1K | -100.70%-41K | -111.38%-14K | 2,107.92%5.85M | 547.37%123K | -70.72%265K |
| Net cash before financing | 23.74%-18.77M | -13.66%-32.85M | -295.93%-24.61M | -75.81%-28.9M | 19.29%-6.22M | -85.08%-16.44M | 8.81%-7.7M | 16.18%-8.88M | -63.17%-8.44M | 51.96%-10.6M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -94.85%837K |
| Refund | ---- | 98.07%-45K | ---- | -194.10%-2.33M | ---- | 61,925.00%2.47M | ---- | 99.27%-4K | ---- | 78.52%-551K |
| Issuing shares | ---- | -54.56%27.8M | ---- | 700.82%61.18M | ---- | -4.21%7.64M | ---- | -16.64%7.98M | ---- | -4.33%9.57M |
| Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 36.61%-71K |
| Issuance expenses and redemption of securities expenses | ---- | 99.64%-9K | ---- | -782.81%-2.52M | ---- | -2,750.00%-285K | ---- | -233.33%-10K | ---- | ---3K |
| Other items of the financing business | -13.30%23.2M | ---- | 116.31%26.76M | ---- | 94.50%12.37M | ---- | -10.23%6.36M | ---- | 2,407.82%7.09M | ---- |
| Net cash from financing operations | -13.30%23.2M | -52.60%25.75M | 116.31%26.76M | 577.63%54.33M | 94.50%12.37M | 58.27%8.02M | -10.23%6.36M | -38.30%5.07M | 2,407.82%7.09M | -58.50%8.21M |
| Effect of rate | 600.90%556K | -195.45%-1.49M | 93.04%-111K | -390.29%-505K | -264.16%-1.6M | -412.12%-103K | 54.56%-438K | -95.74%33K | -138.07%-964K | 185.07%775K |
| Net Cash | 106.14%4.43M | -127.92%-7.1M | -65.05%2.15M | 401.98%25.43M | 559.33%6.16M | -120.68%-8.42M | 1.40%-1.34M | -59.93%-3.82M | 75.21%-1.36M | -5.06%-2.39M |
| Begining period cash | -31.66%18.54M | 1,088.44%27.13M | 1,088.44%27.13M | -78.87%2.28M | -78.87%2.28M | -25.93%10.81M | -23.83%10.81M | -9.94%14.59M | -12.43%14.19M | -16.42%16.2M |
| Cash at the end | -19.34%23.53M | -31.85%18.54M | 326.30%29.17M | 1,091.77%27.21M | -24.21%6.84M | -78.87%2.28M | -23.90%9.03M | -25.93%10.81M | -10.46%11.87M | -9.94%14.59M |
| Cash balance analysis | ||||||||||
| Cash and bank balance | -19.34%23.53M | -31.66%18.54M | 326.30%29.17M | 1,088.44%27.13M | -24.21%6.84M | -78.87%2.28M | -23.90%9.03M | -25.93%10.81M | -10.46%11.87M | -9.94%14.59M |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"